清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

S39 Risk of NTM (non tuberculous mycobacterium) infection in patients on long term prophylactic macrolide antibiotics

医学 克拉霉素 支气管扩张 痰 大环内酯类抗生素 哮喘 抗生素 内科学 慢性阻塞性肺病 重症监护医学 儿科 红霉素 肺结核 肺 病理 幽门螺杆菌 微生物学 生物
作者
JB Adizie,Muhammad Qasim,Manish Pagaria
出处
期刊:Thorax [BMJ]
卷期号:71 (Suppl 3): A24.2-A25 被引量:1
标识
DOI:10.1136/thoraxjnl-2016-209333.45
摘要

Introduction

Long term prophylactic macrolide therapy is commonly used in respiratory diseases characterised by persistent airway inflammation and chronic bacterial infection. There is growing evidence that they possess immuno-regulatory and anti-inflammatory effects as well as an antimicrobial action. The development of macrolide resistant bacteria, particularly NTM infection, is a concern because macrolide therapy is the primary treatment of NTM. There is little published data investigating this risk.

Methods

We identified the cases, retrospectively, of all adult patients who had been given long term continuous prophylactic macrolide therapy attending the respiratory outpatients clinic until January 2016 at Russell Hall Hospital. The clinic letters were reviewed to get a clinical diagnosis and then data regarding sputum culture results were collected from the electronic reporting system. Approximately 75% of cases were reviewed.

Results

226 patient cases were reviewed. 192 (85%) were on long term Clarithromycin. 86 (38%) had a diagnosis of COPD; 133 (59%) of Non CF Bronchiectasis and 100 (44%) of Asthma. The average starting FEV1 was 1.55. The average change in FEV1 was −0.1 (range −3.22 to +1.07). Average time on macrolides was 3 years and 10 months (range 11 months to 8 years and 8 months). Out of all those who had sputum analysed, not one patient demonstrated evidence of NTM infection in their sputum up to 96 months (Figure 1).

Conclusion

Our data suggests that the use of long term prophylactic macrolide therapy in the treatment of respiratory disease does not increase the risk of NTM infection and therefore should not be a concern to limit use in clinical practice. However randomised controlled trials involving larger populations of patients are required to confirm the benefits and harms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
猪敏爱椰枣完成签到,获得积分20
刚刚
慕青的应助被时之王者采纳,获得10
8秒前
kbcbwb2002完成签到,获得积分0
8秒前
蛋卷完成签到 ,获得积分0
10秒前
香蕉觅云的应助被猪敏爱椰枣采纳,获得10
11秒前
111完成签到 ,获得积分10
14秒前
雪山飞龙完成签到,获得积分10
20秒前
优雅的傲柏完成签到,获得积分10
32秒前
1分钟前
英姑的应助被Anywhere采纳,获得10
1分钟前
1分钟前
amiee发布了新的文献求助10
1分钟前
1分钟前
oleskarabach发布了新的文献求助30
1分钟前
笑傲完成签到,获得积分10
1分钟前
蓝意完成签到,获得积分0
1分钟前
时尚靖琪完成签到,获得积分10
1分钟前
顾矜的应助被科研通管家采纳,获得10
1分钟前
Aman完成签到,获得积分10
1分钟前
2分钟前
Anywhere发布了新的文献求助10
2分钟前
多情敏完成签到,获得积分10
2分钟前
crazy完成签到 ,获得积分10
2分钟前
dnpl完成签到,获得积分10
2分钟前
欢呼亦绿完成签到,获得积分10
2分钟前
张秀伟完成签到,获得积分10
2分钟前
Khan完成签到,获得积分10
2分钟前
Anywhere完成签到,获得积分10
2分钟前
Akim的应助被Fighter采纳,获得10
2分钟前
3分钟前
整齐念薇完成签到,获得积分10
3分钟前
Fighter发布了新的文献求助10
3分钟前
文静楷瑞完成签到,获得积分10
3分钟前
3分钟前
3分钟前
lyb1853完成签到 ,获得积分10
3分钟前
大模型的应助被Fighter采纳,获得10
4分钟前
迷路的穆完成签到,获得积分10
4分钟前
4分钟前
Fighter发布了新的文献求助10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190190
求助须知:如何正确求助?哪些是违规求助? 9577298
关于积分的说明 21852333
捐赠科研通 7788645
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560076
邀请新用户注册赠送积分活动 2482902